Source:http://linkedlifedata.com/resource/pubmed/id/16651868
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2006-5-2
|
| pubmed:abstractText |
Malignancy is a major risk factor for venous thromboembolic events, but not all patients with malignancy develop such events. This study attempts to identify risk factors in patients with malignancy who develop venous thromboembolic events. In the current study, 566 consecutive patients without venous thromboembolic events and 416 patients with, admitted to University of Michigan with malignancy between 1992 and 2000, were identified using International Classification of Diseases-9 Clinical Modification codes. Data on potential risk factors was obtained from the University of Michigan Cancer Registry and the medical record. Univariate and multivariate analysis was used to identify factors associated with venous thromboembolic events and mortality. The mean patient age was 45.6 years with a mean survival of 7.8 years from cancer diagnosis. Venous thromboembolic events were associated with solid tumors (odds ratio 5.0; 95% confidence interval 1.7-14.9; P = 0.004), infection (4.9; 1.2-19.8; P = 0.03), and increasing age (1.05; 1.03-1.08; P < 0.001). While leukopenia (4.2; 1.2-14.6; P = 0.02) was associated with an increased incidence of venous thromboembolic events, neutropenia was not. Sex, type of therapy, and cancer stage were not independently associated with venous thromboembolic events. Survival was decreased in patients with venous thromboembolic events (5.9 versus 9.2 years, P < 0.0001). Solid tumors (3.9; 1.8-8.4; P = 0.001), infection (3.3; 1.1-9.9; P = 0.03), advanced stage (1.6; 1.2-2.1; P = 0.001), and increasing age (1.02; 1.0-1.04; P = 0.01) were associated with decreased survival. Patients with malignancy who have solid tumors, advanced age, infection, and leukopenia have a significantly increased risk of venous thromboembolic events.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0957-5235
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
17
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
265-70
|
| pubmed:dateRevised |
2010-11-18
|
| pubmed:meshHeading |
pubmed-meshheading:16651868-Adolescent,
pubmed-meshheading:16651868-Adult,
pubmed-meshheading:16651868-Aged,
pubmed-meshheading:16651868-Aged, 80 and over,
pubmed-meshheading:16651868-Child,
pubmed-meshheading:16651868-Child, Preschool,
pubmed-meshheading:16651868-Cohort Studies,
pubmed-meshheading:16651868-Female,
pubmed-meshheading:16651868-Humans,
pubmed-meshheading:16651868-Infant,
pubmed-meshheading:16651868-Kaplan-Meier Estimate,
pubmed-meshheading:16651868-Male,
pubmed-meshheading:16651868-Middle Aged,
pubmed-meshheading:16651868-Multivariate Analysis,
pubmed-meshheading:16651868-Neoplasm Staging,
pubmed-meshheading:16651868-Neoplasms,
pubmed-meshheading:16651868-Risk Factors,
pubmed-meshheading:16651868-Survival Rate,
pubmed-meshheading:16651868-Venous Thrombosis
|
| pubmed:year |
2006
|
| pubmed:articleTitle |
Risk factors associated with venous thromboembolic events in patients with malignancy.
|
| pubmed:affiliation |
Department of Surgery, Section of Vascular Surgery, University of Michigan, Ann Arbor, 48109-0329, USA.
|
| pubmed:publicationType |
Journal Article
|